ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)
NCT06487585
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Vasodilatory Hypotension During or After Cardiac Surgery
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of Maryland St. Joseph Medical Center
- Last updated on ClinicalTrials.gov
- December 22, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- University of Maryland St. Joseph Medical Center · Towson, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.